BARD1β showed a trend toward reduced apoptosis at baseline and low-dose treatment, though this was not significant at higher concentrations.
1
—
—
BARD1β showed a trend toward reduced apoptosis at baseline and low-dose treatment, though this was not significant at higher concentrations.